Description
- Reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking
- To increase your success in Quitting
- For those who smoke their first cigarette more than 30 minutes after waking up
- WARNING: Cancer and Reproductive Harm – www.P65Warnings.ca.gov.
| SKU # | 523886 |
| Manufacturer # | 00135019502 |
| Brand | Nicoderm CQ® |
| Manufacturer | Glaxo Consumer Products |
| Country of Origin | Unknown |
| Active Ingredients | Nicotine Polacrilex |
| Application | Stop Smoking Aid |
| Dosage Form | Transdermal Patch |
| FSA Eligible - Buy UOM | Yes |
| FSA Eligible - Primary UOM | Yes |
| FSA Eligible - Sell UOM | Yes |
| Generic Drug Code | 03422 |
| Is_Active_Vendor | Y |
| Is_DSCSA | N |
| Is_Discontinued | N |
| Is_Medical_Device | N |
| Lot_Tracking_Flag | N |
| NDC Number | 00135019502 |
| On_Allocation | N |
| Product Dating | McKesson Acceptable Dating: we will ship >= 180 days |
| Strength | 14 mg Strength |
| Supplier_ID | 3885243 |
| UNSPSC Code | 51143218 |
| Volume | 14 per Box |
